BioSpace News Archive

Pharm Country

Evergreen Theragnostics Expands Alpha Radiopharmaceutical Production Capabilities

Evergreen Theragnostics, Inc., a leading radiopharmaceutical Contract Development and Manufacturing Organization, has undertaken an important strategic expansion at its manufacturing facility in Springfield, NJ

July 15, 2021
·
3 min read
Vivasure Medical Announces Development of Sutureless Venous Closure Device for Use in Percutaneous Transcatheter Procedures

Vivasure Medical today announced its development program for PerQseal ® Blue, the company’s new investigational product.

July 15, 2021
·
3 min read
Business

Viz.ai and Avicenna.AI Partner to Launch World-class AI-Driven Intelligent Care Coordination for Pulmonary Embolism and Aortic Disease

Viz.ai, the world leader in AI-driven intelligent care coordination, has partnered with Avicenna.AI, a global leader in artificial intelligence solutions, to enable intelligent care coordination and improve patient triage of patients suffering from pulmonary embolism (PE) and aortic disease

July 15, 2021
·
4 min read
Drug Development

Bio-Thera Solutions Announces the First Patient Dosed in Phase III Clinical Trial for BAT2206, a Proposed Biosimilar of Stelara® (Ustekinumab)

Bio-Thera Solutions, Ltd. today announced that the first patient has been dosed in a Phase III clinical study for BAT2206, a proposed biosimilar of Stelara® (ustekinumab).

July 15, 2021
·
4 min read
NLS Pharmaceutics Announces FDA Acceptance of IND Application to Initiate Clinical Trials with Quilience(R) (mazindol ER) to Treat Narcolepsy

NLS Pharmaceutics Ltd. announces that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug application

July 15, 2021
·
4 min read
Drug Development

Vir Biotechnology Initiates Phase 2 Clinical Trial Evaluating the Combination of VIR-2218 and VIR-3434 as a Functional Cure Regimen for Chronic Hepatitis B Virus Infection

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the first patient has been dosed in the Phase 2 MARCH trial evaluating VIR-2218 together with VIR-3434 for the treatment of patients with chronic hepatitis B virus (HBV) infection.

July 15, 2021
·
5 min read
Business

Aeglea BioTherapeutics Appoints Jim Kastenmayer as General Counsel

Aeglea BioTherapeutics, Inc. today announced the appointment of Jim Kastenmayer , Ph.D., J.D., as general counsel.

July 15, 2021
·
4 min read
Policy

Clarus Therapeutics Announces Comprehensive Settlement of Patent Litigation With Lipocine

Clarus and Lipocine (NASDAQ: LPCN) agreed to settle all outstanding claims in the patent infringement lawsuit brought against Clarus by Lipocine and to further resolve a patent interference between the parties.

July 15, 2021
·
8 min read
Biotech Bay

Denali Therapeutics to Present Interim Data from Phase 1/2 Study of ETV:IDS (DNL310) for the Potential Treatment of Hunter Syndrome at MPS 2021Management to host webinar for analysts and investors on July 25th

Denali Therapeutics Inc. today announced its participation at MPS 2021, the 16 th Annual International Symposium of MPS and Related Diseases

July 15, 2021
·
5 min read
Biotech Beach

Emmaus Life Sciences Announces Submission of Endari® Marketing Authorization Application in Kuwait

Emmaus Life Sciences, Inc. announced today the submission of its application for Marketing Authorization (MA) for Endari® to the Kuwait Drug and Food Control (KDFC).

July 15, 2021
·
4 min read